Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Phibro Animal Health Corporation (PAHC)

38.87 +0.99 (+2.60%)
As of 11:30:30 AM EDT. Market Open.
Trade PAHC on Coinbase
Chart Range Bar
Loading chart for PAHC
  • Previous Close 37.88
  • Open 38.35
  • Bid 26.47 x 200
  • Ask 48.00 x 200
  • Day's Range 38.28 - 38.87
  • 52 Week Range 28.25 - 60.08
  • Volume 16,126
  • Avg. Volume 222,279
  • Market Cap (intraday) 1.578B
  • Beta (5Y Monthly) 0.42
  • PE Ratio (TTM) 15.99
  • EPS (TTM) 2.43
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield 0.48 (1.27%)
  • 1y Target Est 47.00
  • Motley Fool Rating Bullish

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

www.pahc.com

2,605

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PAHC
5.04%
S&P 500 (^GSPC)
12.90%

1-Year Return

PAHC
4.47%
S&P 500 (^GSPC)
12.17%

3-Year Return

PAHC
284.79%
S&P 500 (^GSPC)
87.71%

5-Year Return

PAHC
100.65%
S&P 500 (^GSPC)
67.82%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY26
Revenue 396.7M
Earnings 21.7M
Profit Margin 5.47%

Q1

FY26

Q2

FY26

Q3

FY26

Q4

FY26

0
100M
200M
300M
5.5%
6.0%
6.5%
7.0%

Analyst Insights

View More

Analyst Price Targets

37.00
47.00 Average
38.87 Current
55.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 5/14/2026
Analyst Citigroup
Rating Action Maintains
Rating Neutral
Price Action Lowers
Price Target 62 -> 44

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.57%

  • Return on Assets (ttm)

    8.48%

  • Return on Equity (ttm)

    29.72%

  • Revenue (ttm)

    1.52B

  • Net Income Avi to Common (ttm)

    99.72M

  • Diluted EPS (ttm)

    2.43

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    83.98M

  • Total Debt/Equity (mrq)

    206.41%

  • Levered Free Cash Flow (ttm)

    -19.3M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: